Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Efficacy of Melatonin and Osteogenic Loading on Bone Health in an Osteopenic Population: MelaOstrong Study

NCT04233112 is registered in ClinicalTrials.gov with Duquesne University as lead sponsor.

NCT NCT04233112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04233112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Efficacy of Melatonin and Osteogenic Loading on Bone Health in an Osteopenic Population: MelaOstrong Study
Lead sponsor
Duquesne University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
May 26, 2020
Completion date
September 1, 2025
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteopenia